台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

TSF-1_Lower urinary tract dysfunction in prader-willi_趙梓辰

2023-02-08 • 觀看: 6 • 回應: 0 • ppt
LS2-2_Can medical treatment change the natural history BPO_黃逸修

2023-02-07 • 觀看: 4 • 回應: 0 • ppt
LS2-1_How Good do Current LHRH Agonists Control Testosterone Can this be Improved with Eligard_林仁泰

2023-02-07 • 觀看: 17 • 回應: 0 • ppt
SF1-1_做對運動，讓別人猜年紀都少一輪_洪聰敏

2023-02-07 • 觀看: 3 • 回應: 0 • ppt
TSD-3_How to optimize evaluation of renal transplant recipient to prevent antibody-mediated rejection_盧嘉文

2023-02-07 • 觀看: 5 • 回應: 0 • ppt
TSD-2_Experience of ABO-incompatible kidney transplantation in transplant team of CMUH_蕭博任

2023-02-07 • 觀看: 4 • 回應: 0 • ppt
TSD-1_Update of protocol about preparation and care of HLA positive and ABO incompatible kidney transplantation_王碩盟

2023-02-07 • 觀看: 3 • 回應: 0 • ppt
TSC-2_Front line treatment for metastatic renal cell carcinoma an update_魏子鈞

2023-02-07 • 觀看: 5 • 回應: 0 • ppt
TSC-1_Updates of adjuvant therapy in renal cell carcinoma_洪健華

2023-02-07 • 觀看: 32 • 回應: 0 • ppt
TSB-2_Advanced prostate cancer 2022 update_虞凱傑

2023-02-07 • 觀看: 12 • 回應: 0 • ppt
TSB-1_Epigenetic regulation of lineage plasticity and anti-androgen resistance in neuroendocrine prostate cancer (NEPC)_張佩靖

2023-02-07 • 觀看: 2 • 回應: 0 • ppt
TSA-2_Biomarkers in urothelial carcinoma_王紹全

2023-02-07 • 觀看: 7 • 回應: 0 • ppt

Prev
277
278
279
280
281
282
283
284
285
286
Next
/ 1056